Formulation and In-Vitro Characterization of Chitosan-Nanoparticles Loaded with the Iron Chelator Deferoxamine Mesylate (DFO)
The objective of this study was to develop chitosan (CS) nanoparticles (NPs) loaded with deferoxamine mesylate (DFO) for slow release of this iron-chelating drug. Drug nanoencapsulation was performed via ionic gelation of chitosan using sodium tripolyphosphate (TPP) as cross-linker. Nanoparticles wi...
Main Authors: | Maria Lazaridou, Evi Christodoulou, Maria Nerantzaki, Margaritis Kostoglou, Dimitra A. Lambropoulou, Angeliki Katsarou, Kostas Pantopoulos, Dimitrios N. Bikiaris |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/3/238 |
Similar Items
-
Preparation and optimization of polymeric micelles as an oral drug delivery system for deferoxamine mesylate: in vitro and ex vivo studies
by: Anayatollah Salimi, et al.
Published: (2019-01-01) -
Preparation and characterization of topical solid lipid nanoparticles containing deferoxamine
by: Behzad Sharif Makhmalzade, et al.
Published: (2021-09-01) -
A Water-Soluble Chitosan Derivative for the Release of Bioactive Deferoxamine
by: Georgia Michailidou, et al.
Published: (2024-01-01) -
Investigation of the parameters affecting the release of flurbiprofen from chitosan microspheres
by: Müşerref Günseli Yüksel Tilkan, et al.
Published: (2018-04-01) -
Chitosan Derivatives with Mucoadhesive and Antimicrobial Properties for Simultaneous Nanoencapsulation and Extended Ocular Release Formulations of Dexamethasone and Chloramphenicol Drugs
by: Aikaterini Karava, et al.
Published: (2020-06-01)